Today: 10 June 2026
Strategy (MSTR) stock price slips with Bitcoin ahead of Feb. 5 earnings

Strategy (MSTR) stock price slips with Bitcoin ahead of Feb. 5 earnings

New York, February 3, 2026, 11:27 (EST) — Regular session

  • Strategy shares dipped as Bitcoin slid in U.S. morning trading
  • A recent SEC filing revealed a fresh Bitcoin purchase financed through at-the-market share sales
  • Investors are eyeing Thursday’s results for insights into funding and exposure

Shares of Strategy Inc dropped roughly 2.5% Tuesday, tracking Bitcoin’s slip of about 3% to near $76,700. By 11:27 a.m. in New York, the stock had fallen $3.53 to $136.10.

This move is notable because the company’s balance sheet essentially functions as a Bitcoin play in public markets. In a filing with the U.S. Securities and Exchange Commission on Monday, Strategy revealed holdings of 713,502 bitcoins as of Feb. 1, bought at an average price of $76,052 each. It added 855 bitcoins last week, spending $75.3 million. The purchases were financed by selling 673,527 shares via an at-the-market offering, which brought in about $106 million, according to the filing.

Bitcoin’s break-even zone has become a clear marker for traders. Executive chairman Michael Saylor posted on X that the company “has acquired 855 BTC for ~$75.3 million,” highlighting just how tightly the stock’s moves now track the cryptocurrency’s daily fluctuations. X (formerly Twitter)

Strategy plans to release its fourth-quarter results after the U.S. market closes on Feb. 5. The company will also hold a live video webinar at 5 p.m. Eastern to go over the details.

The company has moved to clarify how it handles preferred-stock payouts. Strategy reported that 100% of the 2025 distributions on its perpetual preferred “Digital Credit” instruments are classified as a non-taxable return of capital for U.S. federal tax purposes—meaning investors generally reduce their cost basis instead of paying tax as dividend income. In 2025, it raised $5.5 billion from five IPOs of these securities, added another $1.9 billion through at-the-market programs, and has paid out $413 million in total distributions. Strategy

On Tuesday, shares of Coinbase Global dropped 3.4%, while other crypto-related stocks showed mixed results.

Several strategists warn of further bitcoin losses if it fails to find a foothold soon. John Blank at Zacks Investment Research cautioned the price might dip “as low as $40,000.” Fundstrat Global Advisors’ Tom Lee pointed to gains in precious metals as “a vortex sucking all risk appetite” out of crypto. Investopedia

Equity holders know the drill: the strategy often acts like a leveraged Bitcoin proxy, but it relies on continually attracting new investors. That dynamic can amplify both gains and losses.

The downside is clear. Should Bitcoin’s decline persist, investors will zero in on dilution from additional stock offerings and the burden of preferred dividend payments, particularly if appetite for risk continues to fade across crypto markets.

Traders are eyeing if Bitcoin can stay above the mid-$70,000 level. All eyes also turn to Strategy’s Feb. 5 earnings, which will shed light on its financing pace and Bitcoin approach.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split
Previous Story

Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Next Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Go toTop